牛牛AI助理已提取核心訊息
On January 22, 2024, Merck & Co., Inc. (MRK) EVP and General Counsel, Jennifer Zachary, completed a purchase of 23,298 shares of the company's common stock at a price of $119.43 per share. Following this transaction, Zachary's direct holdings in Merck & Co. increased to a total of 59,139.76 shares. The transaction, which is part of the company's stock acquisition plans, signifies a bolstering of insider confidence in the pharmaceutical giant's stock.
On January 22, 2024, Merck & Co., Inc. (MRK) EVP and General Counsel, Jennifer Zachary, completed a purchase of 23,298 shares of the company's common stock at a price of $119.43 per share. Following this transaction, Zachary's direct holdings in Merck & Co. increased to a total of 59,139.76 shares. The transaction, which is part of the company's stock acquisition plans, signifies a bolstering of insider confidence in the pharmaceutical giant's stock.
2024年1月22日，默沙東公司（MRK）執行副總裁兼總法律顧問詹妮弗·扎卡里以每股119.43美元的價格完成了對23,298股公司普通股的收購。在這筆交易之後，扎卡里在默沙東公司的直接持股量增加到總共59,139.76股。該交易是該公司股票收購計劃的一部分，標誌着內部人士對這家制藥巨頭股票的信心得到增強。
2024年1月22日，默沙東公司（MRK）執行副總裁兼總法律顧問詹妮弗·扎卡里以每股119.43美元的價格完成了對23,298股公司普通股的收購。在這筆交易之後，扎卡里在默沙東公司的直接持股量增加到總共59,139.76股。該交易是該公司股票收購計劃的一部分，標誌着內部人士對這家制藥巨頭股票的信心得到增強。
有用
沒用